Carlo Buonerba
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Prostate Cancer Treatment and Research 32
- Renal cell carcinoma treatment 14
- Prostate Cancer Diagnosis and Treatment 13
- Oncology 35
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Giuseppe Di Lorenzo (92 shared papers)Matteo Ferro (35 shared papers)Sabino De Placido (42 shared papers)Daniela Terracciano (17 shared papers)Guru Sonpavde (21 shared papers)Piera Federico (18 shared papers)Sisto Perdonà (16 shared papers)Riccardo Autorino (8 shared papers)
- Journals
- Medicine (7 papers)Critical Reviews in Oncology/Hematology (7 papers)Future Oncology (6 papers)Anti-Cancer Drugs (5 papers)Journal of Clinical Oncology (5 papers)
- Partner nations
- ItalyUnited StatesCanada
In The Last Decade
Carlo Buonerba
114 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 136
- Pulmonary and Respiratory Medicine 1.0k
- Cancer Research 463
- Oncology 492
- Surgery 588
- Urology 62
Countries citing papers authored by Carlo Buonerba
This map shows the geographic impact of Carlo Buonerba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Buonerba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Buonerba more than expected).
Fields of papers citing papers by Carlo Buonerba
This network shows the impact of papers produced by Carlo Buonerba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Buonerba. The network helps show where Carlo Buonerba may publish in the future.
Co-authors
The 25 scholars most cited alongside Carlo Buonerba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 179 | |
| 2 | 2017 | 114 | |
| 3 | 2010 | 102 | |
| 4 | 2011 | 96 | |
| 5 | 2013 | 87 | |
| 6 | 2010 | 79 | |
| 7 | 2011 | 74 | |
| 8 | 2021 | 73 | |
| 9 | 2022 | 70 | |
| 10 | 2013 | 70 | |
| 11 | 2010 | 66 | |
| 12 | 2012 | 64 | |
| 13 | 2011 | 58 | |
| 14 | 2014 | 56 | |
| 15 | 2015 | 55 | |
| 16 | 2012 | 53 | |
| 17 | 2016 | 51 | |
| 18 | 2016 | 50 | |
| 19 | 2017 | 50 | |
| 20 | 2019 | 49 |
About Carlo Buonerba
Carlo Buonerba is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 123 papers that have together received 2.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (32 papers), Renal cell carcinoma treatment (14 papers), Prostate Cancer Diagnosis and Treatment (13 papers), Cancer, Lipids, and Metabolism (12 papers), Bladder and Urothelial Cancer Treatments (11 papers), Genital Health and Disease (9 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.0k citations), Cancer Research (463 citations), Oncology (492 citations), Surgery (588 citations) and Urology (62 citations). Carlo Buonerba has collaborated with scholars based in Italy, United States and Canada. Frequent co-authors include Giuseppe Di Lorenzo, Matteo Ferro, Sabino De Placido, Daniela Terracciano, Guru Sonpavde, Piera Federico, Sisto Perdonà, Riccardo Autorino, Giuseppe Lucarelli and Giovannella Palmieri. Their work appears in journals such as Medicine, Critical Reviews in Oncology/Hematology, Future Oncology, Anti-Cancer Drugs and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.